Denosumab vs. bisphosphonates in primary osteoporosis: a meta-analysis of comparative safety in randomized controlled trials
Takaomi Kobayashi, Tadatsugu Morimoto, Koji Ito, Masaaki Mawatari, Takafumi Shimazaki
Topics & Concepts
DenosumabMedicineRelative riskInternal medicineClinical endpointAdverse effectOsteoporosisRandomized controlled trialMeta-analysisConfidence intervalBone health and treatmentsBone health and osteoporosis researchBone and Joint Diseases